Evaluation of Oncological Hyperthermia Centers and Turkey Modeling

The newest technology and latest therapeutic procedures are utilized in cancer treatment in Turkey; however, oncological hyperthermia equipment is not available in this country.

This study aimed to demonstrate the necessity of oncological hyperthermia devices in Turkey where cancertreatment is performed effectively. In this direction, some important oncological hyperthermia centers have been examined to determine what kind of planning can be developed in this country.

The data were collected considering the number of patients who undergoing hyperthermia during the cancer treatment, varieties in cancer types, devices per population, and rate of hyperthermia use. Subsequently, a model was prepared for Turkey, and an evaluation was performed on the number of cancer cases that can be applied to this treatment and the need for the number of oncological hyperthermia devices.

According to the results, 375 patients, on average, are treated annually using a hyperthermia device in the cancer treatment centers. According to the estimations, 400 cases can benefit from per hyperthermia device annually, on average, and there are 0.18 hyperthermia devices per one million population in Turkey. Therefore, given the present population and the rates of cancer diagnosis annually, 13 deep regional hyperthermia devices are required across Turkey for cancer treatment.

Deep regional hyperthermia along with modern radiotherapy devices play a vital role in cancer treatmentin comprehensive oncology-related centers. This condition accompanied by a sufficient number of radiation oncologists will affect the capacity to facilitate access to cancer treatment options significantly.